奥莱玛制药

最新新闻

• 评级变动
  Guggenheim Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $16 to $59
  \u5e02\u573a\u8d44\u8baf · 2026/9/14
• 评级变动
  LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29
  \u5e02\u573a\u8d44\u8baf · 2026/5/18
• Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $59
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $62
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• Stifel Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/5/26
• 评级变动
  LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $52
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $23 to $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $20 to $59
  \u5e02\u573a\u8d44\u8baf · 2026/8/11

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。